Enhanced expansion and cytotoxicity of engineered natural killer cells and uses thereof

NZ835621APending Publication Date: 2026-07-31NKARTA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ835621
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-09-02
Filing Date
2021-08-31
Publication Date
2026-07-31

Smart Images

  • Figure 1_ABST
    Figure 1_ABST
Patent Text Reader

Abstract

Several embodiments disclosed herein relate to methods and compositions for enhanced expansion of NK cells in culture. In several embodiments, the methods utilize one or more soluble interleukins as culture media supplements at one or more time points during expansion of the NK cell, or other immune cell, the expansion employing a feeder cell population.
Need to check novelty before this filing date? Find Prior Art